Soufflé Therapeutics
Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.
$135MSeries B
ParticipantT
Temasek
Activity from announced rounds
Activity in this selectionOct 17, 2026 · Sep 18, 2026
Temasek is a Singapore investment company with global public and private holdings, investing around digitisation, sustainable living, the future of consumption and longer lifespans.
Its global direct investments target both emerging and established market leaders. The four structural themes cut across industries: AI and computing, renewable energy and industrial decarbonisation, changing consumer demand and health-related innovation.
Temasek’s portfolio also includes Singapore-based companies and partnerships with fund managers. Since April 2026, its organisational structure separates global direct investments, Singapore holdings and partnership solutions, giving these distinct investment activities dedicated teams.
Sources
- Rounds participated in
- 3
- Confirmed lead rounds
- 2 All roles disclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $940M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionVinci
Vinci develops AI systems designed to model physical behavior and help robots and other machines operate in real-world environments.
$250MSeries B
LeadDevoted Health
Devoted Health brings Medicare Advantage coverage together with medical care, virtual visits, in-home services and Member Service Guides for older adults.
$555MSeries G
Lead